Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-001893

CEO sold 22,430 shares at an average $76.67 ($1,719,741)

  • CEO acquired 25,350 shares (option exercise)
  • CEO gave 2,920 shares (gift)
  • CEO gave 2,920 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Zovighian Bernard J · CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Exercise or conversion : show line 1 in the form +25,350 $59.26 $1,502,157 106,326 D
2026-02-12 Sale : show line 2 in the form −2,532 $77.13 $195,290 103,794 D
2026-02-12 Sale : show line 3 in the form −19,898 $76.61 $1,524,451 83,896 D
2026-02-13 Gift : show line 4 in the form −2,920 80,976 D
2026-02-13 Gift : show line 5 in the form +2,920 11,516.55 I
Open-market sales · 22,430 sh · avg $76.67 · $1,719,741

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-12 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Acquire) −25,350 0 D
Loading xslF345X05/doc4.xml…